Real-time CGM: The FIRST Tool for Managing Type 2 Diabetes

Achieving glycemic goals early in the diagnosis of type 2 diabetes improves the chances of maintaining A1C goals over time. There is also a “legacy effect” where reaching A1C targets in the first year of treatment results in sustained, long-term improvements in health, even if A1C levels rise over time.1 One tool to help reach glycemic goals early is using real-time continuous glucose monitoring (RT-CGM). 

Watch this short 6-minute video as Thomas Grace, MD, CDCES, Board-Certified in Family Medicine, Director, Blanchard Valley Diabetes Center, Findlay, Ohio, describes the value of using RT-CGM early in the diagnosis of type 2 diabetes to “turn the lights on” and view the full picture of diabetes glycemic metrics.

Dr. Grace completed his Family Medicine residency at Beaumont Hospital, Detroit, Michigan. He is also board certified in Obesity Medicine and is a certified Diabetes Care and Education Specialist. He is a member of the American Diabetes Association serving on several state and local boards. Currently he’s the director of the Blanchard Valley Diabetes Center, Findlay, Ohio, where he provides compassionate care for his patients focused on education and wellbeing. 

Dr. Grace is an employee of Dexcom
1. Powell, RE et al., Strategies for overcoming therapeutic inertia in type 2 diabetes: A systematic review and meta-analysis. Diabetes Obes Metab. 2021;23:2137–2154 DOI: 10.1111/dom.14455 

Was this resource helpful?